76 related articles for article (PubMed ID: 33228353)
1. L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal Cells.
Montaser AB; Järvinen J; Löffler S; Huttunen J; Auriola S; Lehtonen M; Jalkanen A; Huttunen KM
ACS Chem Neurosci; 2020 Dec; 11(24):4301-4315. PubMed ID: 33228353
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1.
Singh N; Ecker GF
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695141
[TBL] [Abstract][Full Text] [Related]
3. Progress in drug delivery to the central nervous system by the prodrug approach.
Pavan B; Dalpiaz A; Ciliberti N; Biondi C; Manfredini S; Vertuani S
Molecules; 2008 May; 13(5):1035-65. PubMed ID: 18560328
[TBL] [Abstract][Full Text] [Related]
4. Improving drug delivery to the brain: the prodrug approach.
Huttunen KM
Expert Opin Drug Deliv; 2024 May; ():1-11. PubMed ID: 38738934
[TBL] [Abstract][Full Text] [Related]
5. PEPT1-mediated prodrug strategy for oral delivery of peramivir.
Sun Y; Gan W; Lei M; Jiang W; Cheng M; He J; Sun Q; Liu W; Hu L; Jin Y
Asian J Pharm Sci; 2018 Nov; 13(6):555-565. PubMed ID: 32104429
[TBL] [Abstract][Full Text] [Related]
6. Functional Polarity of Microvascular Brain Endothelial Cells Supported by Neurovascular Unit Computational Model of Large Neutral Amino Acid Homeostasis.
Taslimifar M; Buoso S; Verrey F; Kurtcuoglu V
Front Physiol; 2018; 9():171. PubMed ID: 29593549
[TBL] [Abstract][Full Text] [Related]
7. Research progress of prodrugs for the treatment of cerebral ischemia.
Zheng H; Wu H; Wang D; Wang S; Ji D; Liu X; Gao G; Su X; Zhang Y; Ling Y
Eur J Med Chem; 2024 Jun; 272():116457. PubMed ID: 38704941
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Characterization of LAT1 Cholesterol-Binding Sites.
Hutchinson K; Schlessinger A
J Chem Theory Comput; 2024 Apr; 20(8):3349-3358. PubMed ID: 38597304
[TBL] [Abstract][Full Text] [Related]
9. Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery.
Kou L; Yao Q; Zhang H; Chu M; Bhutia YD; Chen R; Ganapathy V
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33019627
[TBL] [Abstract][Full Text] [Related]
10. A new type of blood-brain barrier aminoacidopathy underlies metabolic microcephaly associated with SLC1A4 mutations.
Odeh M; Sajrawi C; Majcher A; Zubedat S; Shaulov L; Radzishevsky A; Mizrahi L; Chung WK; Avital A; Hornemann T; Liebl DJ; Radzishevsky I; Wolosker H
Brain; 2024 Apr; ():. PubMed ID: 38662784
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake.
Venteicher B; Merklin K; Ngo HX; Chien HC; Hutchinson K; Campbell J; Way H; Griffith J; Alvarado C; Chandra S; Hill E; Schlessinger A; Thomas AA
ChemMedChem; 2021 Mar; 16(5):869-880. PubMed ID: 33230949
[TBL] [Abstract][Full Text] [Related]
12. T Cell-Mediated Transport of Polymer Nanoparticles across the Blood-Brain Barrier.
Ayer M; Schuster M; Gruber I; Blatti C; Kaba E; Enzmann G; Burri O; Guiet R; Seitz A; Engelhardt B; Klok HA
Adv Healthc Mater; 2021 Jan; 10(2):e2001375. PubMed ID: 33241667
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1.
Stocki P; Szary J; Rasmussen CLM; Demydchuk M; Northall L; Logan DB; Gauhar A; Thei L; Moos T; Walsh FS; Rutkowski JL
FASEB J; 2021 Feb; 35(2):e21172. PubMed ID: 33241587
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Enhanced BBB Penetration Studies of L-serine-Tethered Nipecotic Acid-Prodrug.
Dhanawat M; Gupta S; Mehta DK; Das R
Drug Res (Stuttg); 2021 Feb; 71(2):94-103. PubMed ID: 33241549
[TBL] [Abstract][Full Text] [Related]
15. Are NSAIDs Safe? Assessing the Risk-Benefit Profile of Nonsteroidal Anti-inflammatory Drug Use in Postoperative Pain Management.
Chang RW; Tompkins DM; Cohn SM
Am Surg; 2021 Jun; 87(6):872-879. PubMed ID: 33238721
[TBL] [Abstract][Full Text] [Related]
16. Impact of Direction of Transport on the Evaluation of Inhibition Potencies of Multidrug and Toxin Extrusion Protein 1 Inhibitors.
Saito A; Ishiguro N; Takatani M; Bister B; Kusuhara H
Drug Metab Dispos; 2021 Feb; 49(2):152-158. PubMed ID: 33262224
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the stability of prescription drugs in municipal wastewater and sewers based on wastewater-based epidemiology.
Lin W; Huang Z; Gao S; Luo Z; An W; Li P; Ping S; Ren Y
Sci Total Environ; 2021 Feb; 754():142414. PubMed ID: 33254861
[TBL] [Abstract][Full Text] [Related]
18. Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning.
Adasme MF; Bolz SN; Adelmann L; Salentin S; Haupt VJ; Moreno-Rodríguez A; Nogueda-Torres B; Castillo-Campos V; Yepez-Mulia L; De Fuentes-Vicente JA; Rivera G; Schroeder M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233837
[TBL] [Abstract][Full Text] [Related]
19. The use of biostatic human amnion and platelet-rich plasma in topical treatment of toxic epidermal necrolysis-A case report.
Klama-Baryła A; Strzelec P; Pawlik-Knapik D; Cholewa Z; Szapski M; Kitala D; Łabuś W; Kraut M; Smętek W; Kucharzewski M
J Cosmet Dermatol; 2021 Sep; 20(9):2887-2893. PubMed ID: 33232565
[TBL] [Abstract][Full Text] [Related]
20. In-Silico Screening of Lipid-Based Drug Delivery Systems.
Brinkmann J; Exner L; Luebbert C; Sadowski G
Pharm Res; 2020 Nov; 37(12):249. PubMed ID: 33230602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
